Class information for:
Level 1: ACTIVE SURVEILLANCE//WATCHFUL WAITING//PROSTATE SPECIFIC ANTIGEN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1141 2729 29.1 79%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
107 24427 PROSTATE CANCER//RADICAL PROSTATECTOMY//PROSTATECTOMY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ACTIVE SURVEILLANCE Author keyword 144 44% 9% 250
2 WATCHFUL WAITING Author keyword 52 42% 3% 95
3 PROSTATE SPECIFIC ANTIGEN Author keyword 49 12% 15% 398
4 PSA TESTING Author keyword 17 59% 1% 19
5 INSIGNIFICANT PROSTATE CANCER Author keyword 17 70% 1% 14
6 PSA SCREENING Author keyword 14 48% 1% 22
7 PSA VELOCITY Author keyword 14 41% 1% 27
8 ERSPC Author keyword 12 75% 0% 9
9 PSA TEST Author keyword 11 56% 1% 14
10 PROSTATE CANCER SCREENING Author keyword 10 27% 1% 33

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ACTIVE SURVEILLANCE 144 44% 9% 250 Search ACTIVE+SURVEILLANCE Search ACTIVE+SURVEILLANCE
2 WATCHFUL WAITING 52 42% 3% 95 Search WATCHFUL+WAITING Search WATCHFUL+WAITING
3 PROSTATE SPECIFIC ANTIGEN 49 12% 15% 398 Search PROSTATE+SPECIFIC+ANTIGEN Search PROSTATE+SPECIFIC+ANTIGEN
4 PSA TESTING 17 59% 1% 19 Search PSA+TESTING Search PSA+TESTING
5 INSIGNIFICANT PROSTATE CANCER 17 70% 1% 14 Search INSIGNIFICANT+PROSTATE+CANCER Search INSIGNIFICANT+PROSTATE+CANCER
6 PSA SCREENING 14 48% 1% 22 Search PSA+SCREENING Search PSA+SCREENING
7 PSA VELOCITY 14 41% 1% 27 Search PSA+VELOCITY Search PSA+VELOCITY
8 ERSPC 12 75% 0% 9 Search ERSPC Search ERSPC
9 PSA TEST 11 56% 1% 14 Search PSA+TEST Search PSA+TEST
10 PROSTATE CANCER SCREENING 10 27% 1% 33 Search PROSTATE+CANCER+SCREENING Search PROSTATE+CANCER+SCREENING

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SECTION ROTTERDAM 61 95% 1% 20
2 SURVEILLANCE SERIES 43 62% 2% 44
3 PSA VELOCITY 42 48% 2% 64
4 OVERDETECTION 42 75% 1% 30
5 SELECTIVE DELAYED INTERVENTION 37 81% 1% 22
6 INTERPRETING TRENDS 35 52% 2% 48
7 ERSPC 30 68% 1% 26
8 EPSTEIN CRITERIA 30 100% 0% 12
9 ACTIVE SURVEILLANCE 29 17% 6% 157
10 DIGITAL RECTAL EXAMINATION 24 14% 6% 154

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Overdiagnosis and Overtreatment of Prostate Cancer 2014 33 64 78%
Active Surveillance for Prostate Cancer: A Systematic Review of the Literature 2012 124 51 88%
Screening for Prostate Cancer: A Review of the Evidence for the US Preventive Services Task Force 2011 232 69 54%
Screening for Prostate Cancer With the Prostate-Specific Antigen Test A Review of Current Evidence 2014 18 47 81%
Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification 2015 3 52 75%
The Melbourne Consensus Statement on the early detection of prostate cancer 2014 13 14 93%
Active Surveillance for Prostate Cancer: Progress and Promise 2011 103 68 65%
Active surveillance for early-stage prostate cancer - Review of the current literature 2008 134 61 56%
American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale 2013 18 24 88%
Active surveillance for clinically localized prostate cancer--A systematic review 2014 12 57 68%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MED CLIN SCI MALMO 6 100% 0.1% 4
2 DIAGNOST MED IMAGING 4 35% 0.3% 9
3 COPENHAGEN PROSTATE CANC 4 33% 0.3% 9
4 ASSESSMENT MED TECHNOL 3 29% 0.4% 10
5 JAMES BUCHANAN BRADY UROL JOHNS HOPKINS HOSP 3 45% 0.2% 5
6 PROSTATAZENTRUM 3 60% 0.1% 3
7 SURG UROL PATHOL 3 60% 0.1% 3
8 MED GU ONCOL 2 26% 0.3% 8
9 UNIV HOSP UMAS 2 23% 0.3% 9
10 EPIDEMIOL BIOSTATCANC EPIDEMIOL GRP 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000258238 JAMAICA CANC REGISTRY//PROSTATE CANC PROJECT//AFRICAN AMERICAN MEN
2 0.0000198597 PROSTATE SPECIFIC ANTIGEN//FREE PSA//FREE PROSTATE SPECIFIC ANTIGEN
3 0.0000162305 RADICAL PROSTATECTOMY//PROSTATECTOMY//SALVAGE RADIOTHERAPY
4 0.0000131324 FOCAL THERAPY//TARGETED BIOPSY//PROSTATE BIOPSY
5 0.0000109431 PENILE REHABILITATION//CAVERNOUS NERVE//RADICAL PROSTATECTOMY
6 0.0000099400 PCA3//TMPRSS2 ERG//PROSTATE CANCER ANTIGEN 3
7 0.0000080231 PROSTATE US STUDIES//INCIDENTAL PROSTATE CANCER//TRANSRECTAL ULTRASOUND
8 0.0000070953 RNASEL//HEREDITARY PROSTATE CANCER//8Q24
9 0.0000070434 PROSTATE BIOPSY//TRANSRECTAL PROSTATE BIOPSY//PERIPROSTATIC NERVE BLOCK
10 0.0000064838 UNIV INTEGRATED HOSP//DUKE PROSTATE//FREE TESTOSTERONE FT